Literature DB >> 3134602

Safety of therapeutic products used for hemophilia patients.

.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3134602

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


× No keyword cloud information.
  2 in total

1.  Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.

Authors:  M G Ghany; C Leissinger; R Lagier; R Sanchez-Pescador; A S Lok
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 2.  Blood safety and the choice of anti-hemophilic factor concentrate.

Authors:  Leonard A Valentino; Veeral M Oza
Journal:  Pediatr Blood Cancer       Date:  2006-09       Impact factor: 3.167
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.